(Tromsø 18. February 2019) Rolf E. Engstad, CSO of Biotec BetaGlucans
has purchased 30.400 shares in Biotec Pharmacon at NOK 4.17 per share. After
this transaction holds Engstad 581.174 shares and 40.000 options in Biotec
Pharmacon
For further information, please contact

Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no